SHANGHAI, China, Nov. 27 WuXi PharmaTech (Cayman) Inc.(NYSE: WX), a leading pharmaceutical, biotechnology and medical deviceresearch and development outsourcing company with operations in China and theUnited States, today announced Edward Hu, the Company's Chief OperatingOfficer, will present at the 20th Annual Piper Jaffray Healthcare Conferenceon Wednesday, December 3, 2008, at 12:00 pm Eastern Standard Time.
(Photo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The Company will broadcast its presentation. Interested parties mayaccess the broadcast through the Investor Relations section of the Company'sweb site: http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providesbroad and integrated portfolio of laboratory and manufacturing servicesthroughout the drug and medical device R&D process. WuXi PharmaTech'sservices are designed to assist its global partners in shortening the cycleand lowering the cost of drug and medical device R&D. WuXi PharmaTech'soperating subsidiaries are known as WuXi AppTec. For more information, pleasevisit: http://www.wuxiapptec.com .Form more information, please contact: Debra Yu, MD Vice President Strategy WuXi PharmaTech (Cayman) Inc. Tel: +1-215-218-5559 Email: [email protected]
Dr. Hai Mi Executive Director of Investor Relations and Business Planning WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-3726 Email: [email protected]
Juliane Snowden Vice President of Investor Relations Burns McClellan Tel: +1-212-213-0006 Email: [email protected]
SOURCE WuXi PharmaTech (Cayman) Inc.